|
1
|
Osborne C, Wilson P and Tripathy D:
Oncogenes and tumor suppressor genes in breast cancer: potential
diagnostic and therapeutic applications. Oncol. 9:361–377. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ross JS, Fletcher JA, Bloom KJ, Linette
GP, Stec J, Symmans WF, Pusztai L and Hortobagyi GN: Targeted
therapy in breast cancer. Mol Cell Prot. 3:379–392. 2004.
View Article : Google Scholar
|
|
3
|
Tsuda H: HER-2 (c-erbB-2) test update:
present status and problems. Breast Cancer. 13:236–248. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turbett GR, Barnett TC, Dillon ED and
Sellner LN: Single tube protocol for the extraction of DNA or RNA
from paraffin embedded tissues using a starch based adhesive.
Biotech. 20:846–853. 1996.PubMed/NCBI
|
|
5
|
Ausbel FM, Brent R, Kingston RE, Moore DD,
Seidman JG, Smith JA and Struhl K: Short Protocols in Molecular
Biology. 5th edition. John Wiley & Sons; New York: pp.
15122002
|
|
6
|
Königshoff M, Wilhelm J, Bohle RM, Pingoud
A and Hahn M: HER-2/neu gene copy number quantified by real time
PCR: comparison of gene amplification, heterozygosity and
immunohistochemical status in breast cancer tissue. Clin Chem.
49:219–229. 2003.
|
|
7
|
Willmore-Payne C, Holden JA, Zhou H, Gupta
D, Hirschowitz S, Wittwer CT and Layfield LJ: Evaluation of
HER-2/neu gene status in osteosarcoma by fluorescence in situ
hybridization and multiplex and monoplex polymerase chain
reactions. Arch Pathol Lab Med. 130:691–698. 2006.PubMed/NCBI
|
|
8
|
Lal P, Salazar PA, Ladanyi M and Chen B:
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast
carcinomas without HER-2/neu gene amplification. J Mol Diag.
5:155–159. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benöhr P, Henkel V, Speer R, Vogel U,
Sotlar K, Aydeniz B, Reiser A, Neubauer H, Tabiti K, Wallwiener D
and Kurek R: Her-2/neu expression in breast cancer. A comparison of
different diagnostic methods. Anticancer Res. 25:1895–1900.
2005.PubMed/NCBI
|
|
10
|
Merkelbach-Bruse S, Wardelmann E, Behrens
P, Losen I, Buettner R and Friedrichs N: Current diagnostic methods
of HER-2/neu detection in breast cancer with regard to real-time
PCR. Am J Surg Pathol. 27:1565–1570. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kulka J, Tőkés AM, Kaposi-Novák P,
Udvarhelyi N, Keller A, Lotz G and Schaff Z: Detection of HER-2/neu
gene amplification in breast carcinomas using quantitative real
time PCR: a comparison with immunohistochemical and FISH results.
Pathol Oncol Res. 12:197–204. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dobson L, Conway C, Hanley A, Johnson A,
Costello S, O’Grady A, Connolly Y, Magee H, O’Shea D, Jeffers M and
Kay E: Image analysis as an adjunct to manual HER-2
immunohistochemical review: a diagnostic tool to standardize
interpretation. Histophatol. 57:27–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gjerdrum LM, Sorensen BS, Kjeldsen E,
Sorensen FB, Nexo E and Hamilton-Dutoit S: Real time quantitative
PCR of microdissected paraffin-embedded breast carcinoma. J Mol
Diag. 6:42–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lehmann U, Glöckner S, Kleeberger W, Feist
H, von Wasielewski R and Kreipe H: Detection of gene amplification
in archival breast cancer specimens by laser assisted
microdissection and quantitative real time polymerase chain
reaction. Am J Pathol. 156:1855–1864. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Millson A, Suli A, Hartung L, Kunitake S,
Bennett A, Nordberg MCL, Hanna W, Wittwer CT, Seth A and Lyon E:
Comparison of two quantitative polymerase chain reaction methods
for detecting HER2/neu amplification. J Mol Diag. 5:184–190. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Owens MA, Horten BC and Da Silva MM: HER2
amplification ratios by fluorescence in situ hybridization and
correlation with immunohistochemistry in a cohort of 6556 breast
cancer tissues. Clin Breast Cancer. 5:63–69. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tse C, Brault D, Gligorov J, Antoine M,
Neumann R, Lotz JP and Capeau J: Evaluation of the quantitative
analytical methods real time PCR for HER-2 gene quantification and
ELISA of serum HER-2 protein and comparison with fluorescence in
situ hybridization and immnunohistochemistry for determining HER-2
status in breast cancer patients. Clin Chem. 51:1093–1101.
2005.PubMed/NCBI
|
|
18
|
Murphy SK, Magliocco AM and Demetrick DJ:
Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIα
genes in breast carcinoma by quantative real time polymerase chain
reaction using hybridization probes and fluorescence in situ
hybridization. Arch Pathol Lab Med. 129:39–46. 2005.PubMed/NCBI
|
